Uptake mechanism of erythromycin at the blood-placenta barrier

• In: SIG: Individualised Medicine - Posters
• At: Basel (Switzerland) (2008)
• Type: Poster
• Poster code: IM-P-001
• By: SAI, Yoshimichi (Keio University Faculty of Pharmacy, Tokyo, Japan)
• Co-author(s): Takagi, Akinori (Keio University Faculty of Pharmacy, TOKYO, Japan)
  Ochi, Kaori (Keio University Faculty of Pharmacy, TOKYO, Japan)
  Kose, Noriko (Keio University Faculty of Pharmacy, TOKYO, Japan)
  Nishimura, Tomohiro (Keio University Faculty of Pharmacy, TOKYO, Japan)
  Nakashima, Emi (Keio University Faculty of Pharmacy, TOKYO, Japan)
  
• Abstract:

  Infectious diseases in pregnancy increase a risk of serious disorder of fetus including early delivery, abortion and prenatal growth delay. Therefore, antibiotics are used to pregnant women in case benefits outweigh risks. Erythromycin (EM) is a macrolide antibiotics used for chlamydial, syphilis and mycoplasma infections. Although transplacental..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login